FOSUN HEALTH Logo

Cerebral Haemorrhage Causes

catalogue

Cerebral Haemorrhage Causes

Cerebral Haemorrhage Causes

A cerebral haemorrhage is not one disease with one cause. It is the final event of several different processes acting on the small vessels of the brain, and which process it was determines both the risk of bleeding again and what can be done about it. Two mechanisms account for most cases: the small-vessel damage of long-standing high blood pressure, and the protein deposition in vessel walls that becomes common with age. A third group — structural lesions, clotting problems and drugs — is less common overall but far more common in younger patients, and finding it changes the treatment rather than adjusting it.

Long-standing high blood pressure: the commonest mechanism

High blood pressure is the strongest single risk factor for a cerebral haemorrhage, and the mechanism is structural rather than sudden. The arteries that penetrate from the surface of the brain into its depths are small, they branch at right angles, and they carry the full force of arterial pressure across a short distance. Decades of raised pressure thicken and weaken their walls — a change described as lipohyalinosis — until one of them can no longer hold.

That is why the bleeding so often begins deep: the putamen, the thalamus, the pons and the cerebellum are the territories of these vessels, and the deep pattern on a scan is the visible signature of a process that has been running for years. It also explains something patients find counter-intuitive — the process that caused the bleed was established long before, often in someone who felt entirely well.

Cerebral amyloid angiopathy: the lobar bleed of older age

Cerebral amyloid angiopathy is a different process with a different geography. A fragment of protein — the same one implicated in Alzheimer's disease — is deposited in the walls of the small vessels on the surface of the brain and in the leptomeninges, making them brittle and prone to bleeding. Because those vessels sit in the cortex and its coverings, the bleeding they cause is lobar: it appears in the outer rim of a hemisphere rather than in the deep structures.

Its prevalence rises steeply with age, and it is the usual explanation for a lobar haemorrhage in an older patient with normal or well-controlled blood pressure. It is also the mechanism most likely to bleed again, and it often leaves traces that are visible once someone looks for them: small previous bleeds scattered through the lobar regions, and haemosiderin staining along the cortical surface, both shown on MRI sequences sensitive to blood products. Neither is visible on CT, which is why the CT raises the suspicion and the MRI settles it.

Anticoagulants and antiplatelet drugs

Drugs that prevent clots increase the risk of bleeding, and here they do more than that: they make the bleeding larger and harder to stop. Anticoagulants — warfarin and the direct oral anticoagulants — have the strongest effect, which is why their use is specifically sought out in the first minutes of assessment and why reversal is treated as an emergency rather than a task for the ward round. Antiplatelet drugs have a smaller effect on risk, but a patient taking one is still identified deliberately.

It is important to keep the size of this in proportion, because the fear of bleeding leads some patients to stop medication that is protecting them. For most people taking an anticoagulant for atrial fibrillation or a mechanical valve, the drug prevents far more strokes than it causes bleeds, and the correct response to a raised risk is a review of the indication and the dose rather than an unprompted decision to stop.

Structural causes: when the answer is a lesion

In a minority of patients the bleeding is not the disease but a symptom of one. An arteriovenous malformation — a tangle of abnormal vessels connecting arteries directly to veins — can bleed into the brain. An aneurysm usually bleeds into the space around the brain rather than into the tissue itself, but it can produce either pattern. A cavernous malformation, a cluster of thin-walled vessels, tends to bleed slowly and repeatedly rather than catastrophically. A venous sinus thrombosis — a clot in the veins that drain the brain — causes bleeding by raising pressure behind the blockage, and it is treated by treating the clot.

Finding one of these matters because it changes the plan from managing a bleed to treating a lesion, which may be embolised, removed, treated with focused radiation, or in the case of venous thrombosis, treated with anticoagulation — an apparent contradiction that makes sense once the mechanism is understood. The clue that a structural cause is worth hunting for is not a symptom but a pattern: a patient who is younger, who has no history of high blood pressure, whose bleed sits in an unusual position, or who has bled more than once.

A different list in a younger patient

When a haemorrhage occurs in someone young, or in someone whose blood pressure has always been normal, the probabilities shift and the investigation changes accordingly. The list to work through is different, and working through it properly is the difference between treating an event and treating a cause.

Structural lesions — malformations, aneurysms, cavernomas — become more likely and are looked for directly with angiography. Sympathomimetic drugs, cocaine in particular, cause bleeding by driving pressure up abruptly and by injuring vessels, and the history is not always volunteered. Venous sinus thrombosis is more common in younger patients and around pregnancy and the postpartum period, and it requires a specific scan to identify. Inflammatory disease of the vessels, disorders of clotting, and conditions that narrow the arteries of the brain can all present this way.

The practical consequence is that a haemorrhage in a younger adult should widen the investigation rather than narrow it. Explaining an unusual event by the commonest cause is the most frequent way a treatable lesion is missed.

Things that are commonly believed and are not true

"It only happens to people with very high blood pressure." High pressure is the commonest mechanism, but a lobar bleed in an older patient is more often due to amyloid angiopathy, and a younger patient may have a malformation. A normal blood pressure reading does not rule out a haemorrhage, and does not settle its cause.

"Blood thinners must be stopped forever." Sometimes they must, and sometimes they can be restarted after a deliberate assessment of the reason they were prescribed. This is one of the few decisions in medicine where both choices carry a serious risk, and it deserves a considered answer rather than a default one in either direction.

"Surgery is always the answer for bleeding in the brain." Trials comparing routine evacuation with medical management have not shown a benefit for operating on everyone, and surgery is reserved for defined situations — most clearly, a cerebellar bleed compressing the brainstem or blocking the flow of fluid.

"Steroids reduce the swelling." They were studied for exactly this purpose and found to do harm, and they are therefore not used. The swelling around a haematoma is not treated with steroids.

What follows from knowing the cause

Each answer leads somewhere specific. Deep small-vessel disease points to pressure control — the intervention in this condition with the clearest evidence behind it. Amyloid angiopathy points to monitoring, to avoiding unnecessary antithrombotic treatment, and to accepting a higher risk of bleeding again. A structural lesion points to its own treatment, which moves the conversation from managing consequences to removing the cause.

Frequently Asked Questions

Does a normal blood pressure mean the bleed was not caused by pressure?

Not necessarily. Blood pressure is variable, and the reading taken in the emergency department is one moment in a long history that may have included years of raised pressure that was never measured or never treated. That said, a lobar bleed in an older patient with consistently normal pressure is more likely to be caused by cerebral amyloid angiopathy, and a bleed in a younger patient with normal pressure should prompt a search for a structural lesion, a clotting problem or a drug cause rather than being attributed to pressure by default.

Can a brain bleed be caused by medication?

Yes, and it is the medication most often checked first. Anticoagulants — warfarin and the direct oral anticoagulants — increase both the risk of bleeding and the volume of blood lost, which is why their presence is established in the first minutes. Antiplatelet drugs increase the risk modestly. Beyond prescribed medication, cocaine and other sympathomimetic drugs are a recognised cause, particularly in younger patients, and they work both by driving blood pressure up abruptly and by injuring the vessel wall. A family history of bleeding disorders, and any liver or kidney disease, also belong in the same conversation.

Is cerebral amyloid angiopathy hereditary?

Most cases are not. The common form that appears with age is a sporadic condition, and its prevalence rises steeply as people get older — it is best understood as part of the ageing of small vessels rather than as a disease that runs in families. There are, however, rare inherited forms that present much earlier and tend to run in families with recurrent bleeds. Where a younger patient has recurrent lobar haemorrhages with a strong family history, specialist assessment — including genetic evaluation — is appropriate.

Should an anticoagulant be stopped for good after a bleed?

Sometimes yes, sometimes no, and the decision should not be made by default in either direction. Stopping the drug protects against further bleeding; keeping it stopped exposes the patient to the stroke or embolism it was prescribed to prevent. The balance depends on the reason it was prescribed and how serious that risk is, on whether the bleed was deep or lobar — lobar bleeds from amyloid angiopathy recur more often — and on the patient's own priorities. It is settled by the stroke team together with the team that prescribed the drug, and revisited rather than treated as permanent.

Not sure whether the cause has been established?

Send the imaging and the records, and say whether a cause was named and how it was reached. Tell us the blood pressure history rather than a single reading, the full medication list with doses, and anything unusual about the onset or the patient's age. A neurovascular specialist will return a written opinion within about 48 hours of complete records arriving: whether the pattern points to blood pressure or to amyloid angiopathy, whether a structural cause has been adequately excluded, and what remains to be done.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*